News Immunocore announces the presentation of initial data from the Phase 1 ImmTAV® trial for chronic Hepatitis B at the EASL International Liver Congress™ Continue Reading Previous Aleafia Health to Announce Fiscal Year 2022 Fifth Quarter and Year End Results – UpdateNext Arbutus Presents New Data on AB-729, AB-836 and AB-101 at the EASL International Liver Congress™ 2022 and Provides AB-836 Clinical Update Related Stories News Leil Storage Launches SaunaFS 5.0: The First On-Premise HM-SMR Ready Distributed File System Delivering Eco-Efficiency Without Performance Compromise News Hong Kong Book Fair, Sports and Leisure Expo and World of Snacks to reopen earlier at 9am tomorrow with extended evening hours News Imagen Network (IMAGE) Enhances Social Customization with Grok AI Real-Time Processing Engines News iconpractice Launches Version 2.0 of Cloud-Based Chiropractic Practice Management Platform News Power Circuit Productions LLC Announces New Podcast: “The Power Circuit” Hosted by Gaurav Srivastava News Typhoon special arrangements for Hong Kong Book Fair, Hong Kong Sports and Leisure Expo and World of Snacks
